A detailed history of Cwm, LLC transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Cwm, LLC holds 4,999 shares of TVTX stock, worth $85,882. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,999
Previous 1,934 158.48%
Holding current value
$85,882
Previous $16,000 337.5%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$7.89 - $15.21 $24,182 - $46,618
3,065 Added 158.48%
4,999 $70,000
Q2 2024

Jul 09, 2024

BUY
$5.26 - $8.28 $4,602 - $7,244
875 Added 82.63%
1,934 $16,000
Q1 2024

Apr 05, 2024

BUY
$7.18 - $9.82 $143 - $196
20 Added 1.92%
1,059 $8,000
Q4 2023

Feb 01, 2024

BUY
$5.44 - $9.5 $3,557 - $6,213
654 Added 169.87%
1,039 $9,000
Q3 2023

Oct 11, 2023

BUY
$7.64 - $17.25 $1,505 - $3,398
197 Added 104.79%
385 $3,000
Q2 2023

Aug 03, 2023

BUY
$15.3 - $22.61 $2,876 - $4,250
188 New
188 $3,000
Q2 2022

Jul 28, 2022

SELL
$20.94 - $30.01 $1,382 - $1,980
-66 Closed
0 $0
Q1 2022

Apr 21, 2022

BUY
$23.61 - $30.6 $1,558 - $2,019
66 New
66 $2,000

Others Institutions Holding TVTX

About Travere Therapeutics, Inc.


  • Ticker TVTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,173,600
  • Market Cap $1.1B
  • Description
  • Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...
More about TVTX
Track This Portfolio

Track Cwm, LLC Portfolio

Follow Cwm, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.